Violet Light for the Suppression of Myopia

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
Children's Hospital Medical Center, Cincinnati
Study ID
NCT06110520
Status
Recruiting

Conditions

  • Myopia
  • Phototherapy

Eligibility Criteria

Sex
ALL
Age
5 Years - 12 Years
Healthy Volunteers
Accepted

Interventions

  • Violet Light Lamp — DEVICE
    Medical grade lamps with Violet LEDs enabled
  • White Light Lamp — DEVICE
    Standard bedside lamp with standard 4000K LED light bulb.

Study Details

The study explores the suppression of myopia via violet light.

Key Dates

Start date
Jun 7, 2023
Status verified
Dec 2025
Primary completion
Aug 1, 2027
Completion
Jan 1, 2028

Study Design

Enrollment
72 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Violet + / Lens +
    Subjects use a violet light emitting lamp (device intervention - minimally invasive as it's simply a source of light) with CR-39 lenses for their refractive correction. The lamp introduces violet light (Violet +) and the CR-39 lenses allow for the transmission of violet light through the lenses (Lens +).
  • Experimental: Violet + / Lens -
    Subjects use a violet light emitting lamp (device intervention - minimally invasive as it's simply a source of light) with polycarbonate lenses for their refractive correction. The lamp introduces violet light (Violet +) while the polycarbonate lenses block the transmission of violet light through the lenses (Lens -).
  • Placebo Comparator: Violet - / Lens +
    Subjects use a lamp with NO violet light (Violet -) with CR-39 lenses for their refractive correction. CR-39 lenses allow for the transmission of violet light through the lenses (Lens +).

Primary Outcome Measure

Axial Length [ Time Frame: Measured at baseline, and 12 months. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45209
Jillian Eltzroth, MPH
937-403-4996
Melissa Rice, OD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Cincinnati, OH

Related Studies